Which hedge funds own BIOA? BIOAGE LABS INC, Q2 2026 13F holders
42 tracked hedge funds disclosed a position in BIOA (BIOAGE LABS INC) in their Q2 2026 13F filings, worth $434.3m in total. The largest holder by portfolio weight is Octagon Capital Advisors LP at 3.9% of its book. 11 opened a new position this quarter: MPM Bioimpact LLC, Yiheng Capital Management, L.P., Squadron Capital Management LLC, NEXTBio Capital Management LP. 5 exited: ADAR1 Capital Management, LLC, Fox Run Management, L.L.C., Trexquant Investment LP.
- 42
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 11
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 5
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $69.6m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $4.9m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $434m
- Combined value Sum of the holders' reported positions in the security.
- 3.4%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| ADAR1 Capital Management, LLC | 0.1% | $2.4m |
| Fox Run Management, L.L.C. | 0.03% | $172k |
| Trexquant Investment LP | 0.01% | $1.1m |
| Alyeska Investment Group, L.P. | 0.0% | $1.3m |
| Aquatic Capital Management LLC | 0.0% | $15.4k |
Ownership over time
Who discovered BIOA first? Beta
| Octagon Capital Advisors LP | Q4 2025 | +2.2 pts |
| ADAR1 Capital Management, LLC | Q1 2025 | +2.0 pts |
| Cormorant Asset Management, LP | Q3 2024 | +1.4 pts |
| Diadema Partners LP | Q4 2025 | +0.9 pts |
| Stempoint Capital LP | Q1 2026 | +0.5 pts |
| Sofinnova Investments, Inc. | Q3 2024 | −0.6 pts |
| Montanova Capital, LLC | Q3 2024 | −0.9 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.